Afrezza, an inhaled insulin powder, is now available by prescription in U.S. retail pharmacies, Sanofi and MannKind Corp. announced. The drug is approved by the Food and Drug Administration to control high blood sugar in adults who have type 1 and type 2 diabetes.
Energizer's Household Products division introduced a new battery product called Energizer EcoAdvanced. It is the world's first AA battery constructed with 4% recylced batteries, according to the company.
GlaxoSmithKline is gearing up for a Feb. 4 launch of its Flonase Allergy Relief (fluticasone propionate 50 mcg spray), an over-the-counter nasal spray indicated for relief of all nasal and eye-related allergy symptoms.
TyraTech, a life sciences company focusing on nature-derived insect and parasite control products, recently announced that it has secured product listings for its Vamousse head lice product range, including its Vamousse Treatment mousse and Vamousse Protection shampoo, across Walmart and through Cardinal Health.
The Food and Drug Administration announced that it has expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults, making it the first FDA-approved medicine to treat this condition.
Janssen Therapeutics on Thursday announced that the Food and Drug Administration has approved its Prezcobix (darunavir 800 mg/cobicistat 150 mg) tablets. The drug is used to treat human immunodeficiency virus in combination with other antiretovirals for treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions, according to the company.